Cargando…
Benefit risk assessment and update on the use of docetaxel in the management of breast cancer
The objective of this paper is to review the data supporting the use of docetaxel in the treatment of breast cancer, focusing on pharmacokinetics, efficacy in adjuvant and metastatic trials alone and in combination with chemotherapeutic and targeted agents, and the toxicity of docetaxel in compariso...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798099/ https://www.ncbi.nlm.nih.gov/pubmed/24143122 http://dx.doi.org/10.2147/CMAR.S49321 |